Company Amicogen, Inc.

Equities

A092040

KR7092040005

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Bio Therapeutic Drugs

End-of-day quote Korea S.E. Other stock markets 23:00:00 20/05/2024 BST			5-day change	1st Jan Change
7,140 ^KRW	-0.97%		-1.38%	-5.56%

03-20	Amicogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Amicogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Amicogen, Inc. is a Korea-based company engaged in the development, production and distribution of enzymes, bio new materials and healthcare food. The Companyâs products consist of special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins. The Company distributes its products within domestic market and to overseas markets, including China, Japan, the United Sates, Germany and Thailand.

Number of employees: 216

KRW in Million	2022	Weight	2023	Weight	Delta
Raw Drug Substance 75.2 %	107,268	74.3 %	120,222	75.2 %	+12.08%
Biopharmaceutical 34.5 %	48,673	33.7 %	55,181	34.5 %	+13.37%
Consolidated Adjustment -9.7 %	-11,645	-8.1 %	-15,498	-9.7 %	+33.09%

KRW in Million	2022	Weight	2023	Weight	Delta
Overseas 83.1 %	23,284	16.1 %	132,868	83.1 %	+470.63%
South Korea 16.9 %	121,011	83.9 %	27,036	16.9 %	-77.66%

Managers	Title	Age	Since
Cheol Park CEO	Chief Executive Officer	51	12/03/23
Yong-Chul Shin FOU	Founder	63	31/12/99
Sang-Hee Lee DFI	Director of Finance/CFO	44	-
Jun-Ho Kim IRC	Investor Relations Contact	54	-
Young-Jun Park SAM	Sales & Marketing	54	-
Sae-Ki Shin AUD	Comptroller/Controller/Auditor	60	25/03/18

Members of the board	Title	Age	Since
Hong-Gyun Chung BRD	Director/Board Member	63	-
Yong-Chul Shin FOU	Founder	63	31/12/99
Tae-Oh Chung BRD	Director/Board Member	43	25/03/18
Sang-Yup Jeon BRD	Director/Board Member	50	31/12/15
Jeung-Hoon Lee BRD	Director/Board Member	70	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	55,018,347	47,395,413 ( 86.14 %)	202,129 ( 0.3674 %)	86.14 %

Name	Equities	%	Valuation
Yong-Chul Shin 12.53 %	6,891,454	12.53 %	38 M ₩
Lysando AG 2.097 %	1,153,798	2.097 %	6 M ₩
AMICOGEN, INC. 0.7965 %	438,214	0.7965 %	2 M ₩
Cheol Park 0.3248 %	178,704	0.3248 %	993 015 ₩
Jjeo Pyo 0.2820 %	155,172	0.2820 %	862 254 ₩
Young-chul Yoon 0.1344 %	73,920	0.1344 %	410 756 ₩
KB Asset Management Co. Ltd. 0.0286 %	15,740	0.0286 %	87 463 ₩
DFA Australia Ltd. 0.0153 %	8,391	0.0153 %	46 627 ₩
Dimensional Fund Advisors Ltd. 0.007926 %	4,361	0.007926 %	24 233 ₩
Mirae Asset Global Investments Co., Ltd. 0.004400 %	2,421	0.004400 %	13 453 ₩

Name	Equities	%	Valuation
AMICOGEN, INC. 0.80%	438,214	0.80%	2,435,050 $
CLINOMICS INC. 3.52%	1,169,490	3.52%	1,523,109 $

Amicogen, Inc.

64 Dongbu-ro 1259 beon-gil Jinseong-myeon

52621, Jinju-si

+82 5 5759 6161

http://www.amicogen.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
AMICOGEN, INC.	-5.56%	291M
VERTEX PHARMACEUTICALS INCORPORATED	+8.63%	115B
REGENERON PHARMACEUTICALS, INC.	+13.17%	107B
BIONTECH SE	-12.76%	22.31B
ARGENX SE	-3.99%	21.6B
BEIGENE, LTD.	-7.19%	18.23B
WUXI APPTEC CO., LTD.	-39.93%	17.62B
NEUROCRINE BIOSCIENCES, INC.	+6.67%	14.26B
SAREPTA THERAPEUTICS, INC.	+33.90%	12.37B
LEGEND BIOTECH CORPORATION	-28.60%	8.28B

Bio Therapeutic Drugs